| COMPOSITION: | Rabeprazole (as EC inner tablet ) 20 mg & Ondansetron (as IR top layer of tablet) 4 mg Tablets (as Tablet in Tablet formulation) |
| FORMULATION: | TABLETS |
| STATUS: | PRESCRIPTION ONLY DRUG |
| DESCRIPTION: | Renvorab-ON tablets contain Rabeprazole an acid inhibitor and Ondansetron an anti-emetic that stops vomiting. It is indicated in the treatment of hyperacidity and food pipe ulcers associated with various medical, surgical and diagnostic conditions, GERD and to prevent nausea and vomiting due to hyperacidity, indigestion and surgery. |
| SIDE EFFECTS: | Common side effects are headache, constipation, weakness, drowsiness, headache, nausea, vomiting, gas, joint pain, diarrhea and dizziness. |
| DOSAGE/DIRECTIONS FOR USE: | As Prescribed by Physician |
